Fujifilm

, trading as Fujifilm, or simply Fuji, is a Japanese multinational conglomerate headquartered in Tokyo, Japan, operating in the realms of photography, optics, office and medical electronics, biotechnology, and chemicals.
The offerings from the company that started as a manufacturer of photographic films, which it still produces, include: document solutions, medical imaging and diagnostics equipment, cosmetics, pharmaceutical drugs, regenerative medicine, stem cells, biologics manufacturing, magnetic tape data storage, optical films for flat-panel displays, optical devices, photocopiers and printers, digital cameras, color films, color paper, photofinishing and graphic arts equipment and materials.
History.
20th century.
Fuji Photo Film Co., Ltd. was established in 1934 as a subsidiary of Daicel with the aim of producing photographic films. Over the following 10 years, the company produced photographic films, motion-picture films and X-ray films. In the 1940s, Fuji Photo entered the optical glasses, lenses and equipment markets. After the Second World War, Fuji Photo diversified, penetrating the medical (X-ray diagnosis), printing, electronic imaging and magnetic materials fields. In 1962, Fuji Photo and UK-based Rank Xerox Limited (now Xerox Limited) launched Fuji Xerox Co., Ltd. through a joint venture.
From the mid-1950s, Fuji Photo accelerated the establishment of overseas sales bases. In the 1980s, Fuji Photo expanded its production and other bases overseas, stepping up the pace of its business globalization. Meanwhile, Fuji Photo developed digital technologies for its photo-related, medical and printing businesses. As a result, it invented computed radiography (CR), which solved a number of issues of traditional radiography, resulting a decrease of radiation exposure to both technician and patient. Fujifilm's systems were marketed and sold under the FCR brand.
Like its rival Eastman Kodak which dominated in the US, Fuji Photo enjoyed a longtime near-monopoly on camera film in Japan. By becoming one of the title sponsors of the 1984 Los Angeles Olympics (an opportunity that Kodak passed on), offering cheaper camera film, and establishing a film factory in the US, Fuji gained considerable market share there, while Kodak had little success in penetrating Japan. In May 1995, Kodak filed a petition with the US Commerce Department under section 301 of the Commerce Act arguing that its poor performance in the Japanese market was a direct result of unfair practices adopted by Fuji. The complaint was lodged by the US with the World Trade Organization. On January 30, 1998, the WTO announced a "sweeping rejection of Kodak's complaints" about the film market in Japan.
21st century.
The new millennium witnessed the rapid spread of digital technology, and demand for photographic films plunged in line with the growing popularity of digital cameras. In response, Fuji Photo implemented management reforms aimed at drastic transformation of its business structures. Even as early as the 1980s, the company had foreseen the switch from film to digital, so "it developed a three-pronged strategy: to squeeze as much money out of the film business as possible, to prepare for the switch to digital and to develop new business lines." While both film manufacturers recognized this fundamental change, Fuji Photo adapted to this shift much more successfully than Eastman Kodak (which filed for bankruptcy in January 2012). Fuji Photo's diversification efforts also succeeded while Kodak's had failed; furthermore Kodak built up a large but barely profitable digital camera business that was undone quickly by smartphone cameras.
In March 2006, Noritsu and Fuji announced a strategic alliance for Noritsu to manufactures all of Fuji's photofinishing hardware, such as minilabs. Each company produces its own software for the minilabs.
On September 19, 2006, Fujifilm announced plans to establish a holding company, Fujifilm Holdings Corp. Fujifilm and Fuji Xerox would become subsidiaries of the holding company. A representative of the company reconfirmed its commitment to film, which accounts for 3% of sales.
On January 31, 2018, Fujifilm announced that it would acquire a 50.1% controlling stake in Xerox for US$6.1 billion, which will be amalgamated into its existing Fuji Xerox business. The deal was subsequently dropped after intervention by activist investors Carl Icahn and Darwin Deason. In late 2019, Fujifilm announced its acquisition of Xerox's 25% stake in the 57-year-old joint venture, Fuji Xerox.
In December 2019, Fujifilm acquired Hitachi's diagnostic imaging business for US$1.63 billion.
Amid the 2020 COVID-19 pandemic, one of Fujifilm Toyama Chemical drugs, i.e. favipiravir, an antiviral commercially named Avigan, is being considered as a possible cure to the virus, after having been approved by China, Russia, and Indonesia authorities by June 2020.
In June 2020, Fujifilm announced a US$928 million investment to a Denmark-based biologics production facility, which it acquired from Biogen a year earlier for around US$890 million, to double the manufacturing capacity. A tape cartridge using strontium ferrite that could store up to 400TB was showcased by Fujifilm in the late same month.
Subsidiaries.
Fuji Xerox was a joint venture between Fujifilm and Xerox Corporation of North America. After the dissolution of their partnership in 2019, Fujifilm made it a wholly owned subsidiary. In January 2020, the corporate name change was announced, from Fuji Xerox to Fujifilm Business Innovation, effective on April 1, 2021.
Fujifilm bought Sericol Ltd., a UK-based printing ink company specializing in screen, narrow web, and digital print technologies in March 2005.
Fujifilm de México is a Fujifilm subsidiary in Mexico that sells Fujifilm products since 1934 and has been recognized as one of The Best Mexican Companies (Las Mejores Empresas Mexicanas) from 2012 to 2015, a recognition promoted by Banamex, Deloitte México and Tecnológico de Monterrey.
Fujifilm is active in pharmaceutical products and contract manufacturing through its subsidiaries including Fujifilm Toyama Chemical, Fujifilm Diosynth Biotechnologies, etc.
As of July 2020, the Fujifilm Group has two operating companies, which encompass more than 300 subsidiaries in total, and three "shared services companies" under the umbrella. The group structure and a list of some Fujifilm subsidiaries are the following: